|
1
|
Zhang Y, Chen Y, Yu J, Liu G and Huang Z:
Integrated transcriptome analysis reveals miRNA-mRNA crosstalk in
laryngeal squamous cell carcinoma. Genomics. 104:249–256. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu M, Wu H, Liu T, Li Y, Wang F, Wan H,
Li X and Tang H: Regulation of the cell cycle gene, BTG2, by miR-21
in human laryngeal carcinoma. Cell Res. 19:828–837. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Dijk BA, Karim-Kos HE, Coebergh JW,
Marres HA and de Vries E: Progress against laryngeal cancer in The
Netherlands between 1989 and 2010. Int J Cancer. 134:674–681. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hoffman HT, Porter K, Karnell LH, Cooper
JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A and Robinson RA:
Laryngeal cancer in the United States: Changes in demographics,
patterns of care, and survival. Laryngoscope. 116:(Suppl 111).
1–13. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ouyang D, Liu TR, Liu XW, Chen YF, Wang J,
Su X and Yang AK: Combined hyoid bone flap in laryngeal
reconstruction after extensive partial laryngectomy for laryngeal
cancer. Eur Arch Otorhinolaryngol. 270:1455–1462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Diab S, Pascoe J, Shahriar M, Read D,
Kinde H, Moore J, Odani J and Uzal F: Study of laryngopharyngeal
pathology in Thoroughbred horses in southern California. Equine Vet
J. 41:903–907. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Silver CE, Beitler JJ, Shaha AR, Rinaldo A
and Ferlito A: Current trends in initial management of laryngeal
cancer: The declining use of open surgery. Eur Arch
Otorhinolaryngol. 266:1333–1352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ulualp SO: Mapping regional
laryngopharyngeal mechanoreceptor response. Clin Exp
Otorhinolaryngol. 7:319–323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang SY, Lu ZM, Chen LS, Luo XN, Ge PJ,
Song XH, Chen SH and Wu YL: Supracricoid partial laryngectomy
cricohyoidoepiglottopexy (SCPL-CHEP) versus vertical partial
laryngectomy for the treatment of glottic carcinoma. Eur Arch
Otorhinolaryngol. 270:1027–1034. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang HT, Luo H, Wu J, Lan LB, Fan DH, Zhu
KD, Chen XY, Wen M and Liu HM: Galangin induces apoptosis of
hepatocellular carcinoma cells via the mitochondrial pathway. World
J Gastroenterol. 16:3377–3384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Capasso R and Mascolo N: Inhibitory effect
of the plant flavonoid galangin on rat vas deferens in vitro. Life
Sci. 72:2993–3001. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim DA, Jeon YK and Nam MJ: Galangin
induces apoptosis in gastric cancer cells via regulation of
ubiquitin carboxy-terminal hydrolase isozyme L1 and glutathione
S-transferase P. Food Chem Toxicol. 50:684–688. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang W, Tang B, Huang Q and Hua Z:
Galangin inhibits tumor growth and metastasis of B16F10 melanoma. J
Cell Biochem. 114:152–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heo MY, Sohn SJ and Au WW:
Anti-genotoxicity of galangin as a cancer chemopreventive agent
candidate. Mutat Res. 488:135–150. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Agati G, Azzarello E, Pollastri S and
Tattini M: Flavonoids as antioxidants in plants: Location and
functional significance. Plant Sci. 196:67–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Parhiz H, Roohbakhsh A, Soltani F, Rezaee
R and Iranshahi M: Antioxidant and anti-inflammatory properties of
the citrus flavonoids hesperidin and hesperetin: An updated review
of their molecular mechanisms and experimental models. Phytother
Res. 29:323–331. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schultz DR and Harrington WJ Jr:
Apoptosis: Programmed cell death at a molecular level. Semin
Arthritis Rheum. 32:345–369. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tomita T: Cleaved caspase-3
immunocytochemical staining for pancreatic islets and pancreatic
endocrine tumors: A potential marker for biological malignancy.
Islets. 2:82–88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McCormick J, Knight RA, Barry SP,
Scarabelli TM, Abounit K, Latchman DS and Stephanou A: Autophagy in
the stress-induced myocardium. Front Biosci (Elite Ed).
4:2131–2141. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Zhang Q, Tian R, Wang Q, Zhao JJ,
Iglehart JD, Wang ZC and Richardson AL: Lysosomal transmembrane
protein LAPTM4B promotes autophagy and tolerance to metabolic
stress in cancer cells. Cancer Res. 71:7481–7489. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Z, Antalek M, Nguyen L, Li X, Tian X,
Le A and Zi X: The effect of gartanin, a naturally occurring
xanthone in mangosteen juice, on the mTOR pathway, autophagy,
apoptosis, and the growth of human urinary bladder cancer cell
lines. Nutr Cancer. 65:(Suppl 1). 68–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ling YH, Aracil M, Zou Y, Yuan Z, Lu B,
Jimeno J, Cuervo AM and Perez-Soler R: PM02734 (elisidepsin)
induces caspase-independent cell death associated with features of
autophagy, inhibition of the Akt/mTOR signaling pathway, and
activation of death-associated protein kinase. Clin Cancer Res.
17:5353–5366. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhai B, Hu F, Jiang X, Xu J, Zhao D, Liu
B, Pan S, Dong X, Tan G, Wei Z, et al: Inhibition of Akt reverses
the acquired resistance to sorafenib by switching protective
autophagy to autophagic cell death in hepatocellular carcinoma. Mol
Cancer Ther. 13:1589–1598. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Graham TR, Odero-Marah VA, Chung LW,
Agrawal KC, Davis R and Abdel-Mageed AB: PI3K/Akt-dependent
transcriptional regulation and activation of BMP-2-Smad signaling
by NF-kappaB in metastatic prostate cancer cells. Prostate.
69:168–180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pugazhenthi S, Nesterova A, Sable C,
Heidenreich KA, Boxer LM, Heasley LE and Reusch JE: Akt/protein
kinase B up-regulates Bcl-2 expression through cAMP-response
element-binding protein. J Biol Chem. 275:10761–10766. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hale AN, Ledbetter DJ, Gawriluk TR and
Rucker EB III: Autophagy: Regulation and role in development.
Autophagy. 9:951–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li C, Han X, Zhang H, Wu J and Li B: The
interplay between autophagy and apoptosis induced by tanshinone IIA
in prostate cancer cells. Tumour Biol. 37:7667–7674. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Platanias LC: Map kinase signaling
pathways and hematologic malignancies. Blood. 101:4667–4679. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rauch BH, Weber A, Braun M, Zimmermann N
and Schrör K: PDGF-induced Akt phosphorylation does not activate
NF-kappa B in human vascular smooth muscle cells and fibroblasts.
FEBS Lett. 481:3–7. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ryu HJ, Kim JE, Yeo SI and Kang TC:
p65/RelA-Ser529 NF-κB subunit phosphorylation induces autophagic
astroglial death (Clasmatodendrosis) following status epilepticus.
Cell Mol Neurobiol. 31:1071–1078. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Samuels Y and Velculescu VE: Oncogenic
mutations of PIK3CA in human cancers. Cell Cycle. 3:1221–1224.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen K, Song F, He M, Li H, Qian B, Zhang
W, Wei Q and Hao X: Trends in head and neck cancer incidence in
Tianjin, China, between 1981 and 2002. Head Neck. 31:175–182. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li XY, Guo X, Feng S, Li XT, Wei HQ, Yang
HA, Ren Z and Jiang XJ: Relationship between a family history of
malignancy and the incidence of laryngeal carcinoma in the Liaoning
province of China. Clin Otolaryngol. 34:127–131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li S, Chou G, Hseu Y, Yang H, Kwan H and
Yu Z: Isolation of anticancer constituents from flos genkwa (Daphne
genkwa Sieb.et Zucc.) through bioassay-guided procedures. Chem Cent
J. 7:1592013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee LT, Huang YT, Hwang JJ, Lee AY, Ke FC,
Huang CJ, Kandaswami C, Lee PP and Lee MT: Transinactivation of the
epidermal growth factor receptor tyrosine kinase and focal adhesion
kinase phosphorylation by dietary flavonoids: Effect on invasive
potential of human carcinoma cells. Biochem Pharmacol.
67:2103–2114. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Khandelwal VK, Mitrofan LM, Hyttinen JM,
Chaudhari KR, Buccione R, Kaarniranta K, Ravingerová T and
Mönkkönen J: Oxidative stress plays an important role in zoledronic
acid-induced autophagy. Physiol Res. 63:(Suppl 4). S601–S612.
2014.PubMed/NCBI
|
|
37
|
McLeland CB, Rodriguez J and Stern ST:
Autophagy monitoring assay: Qualitative analysis of MAP LC3-I to II
conversion by immunoblot. Methods Mol Biol. 697:199–206. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Giménez-Xavier P, Francisco R, Platini F,
Pérez R and Ambrosio S: LC3-I conversion to LC3-II does not
necessarily result in complete autophagy. Int J Mol Med.
22:781–785. 2008.PubMed/NCBI
|
|
39
|
Kroemer G and Levine B: Autophagic cell
death: The story of a misnomer. Nat Rev Mol Cell Biol. 9:1004–1010.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Reggiori F, Monastyrska I, Verheije MH,
Calì T, Ulasli M, Bianchi S, Bernasconi R, de Haan CA and Molinari
M: Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived
vesicles exporting short-lived ERAD regulators, for replication.
Cell Host Microbe. 7:500–508. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Saini KS, Loi S, de Azambuja E,
Metzger-Filho O, Saini ML, Ignatiadis M, Dancey JE and
Piccart-Gebhart MJ: Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK
pathways in the treatment of breast cancer. Cancer Treat Rev.
39:935–946. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Han L, Yang Y, Yue X, Huang K, Liu X, Pu
P, Jiang H, Yan W, Jiang T and Kang C: Inactivation of PI3K/AKT
signaling inhibits glioma cell growth through modulation of
β-catenin-mediated transcription. Brain Res. 1366:9–17. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lee J, Zhang G, Wu X, Xu F, Zhou J and
Zhang X: Growth inhibitory effect of dihydroartemisinin on
Bcr/Abl+ chronic myeloid leukemia K562 cells involve
AKT, ERK and NF-κB modulation. J Cancer Res Clin Oncol.
138:2095–2102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yip KW and Reed JC: Bcl-2 family proteins
and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Noble P, Vyas M, Al-Attar A, Durrant S,
Scholefield J and Durrant L: High levels of cleaved caspase-3 in
colorectal tumour stroma predict good survival. Br J Cancer.
108:2097–2105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu K, Liu PC, Liu R and Wu X: Dual AO/EB
staining to detect apoptosis in osteosarcoma cells compared with
flow cytometry. Med Sci Monit Basic Res. 21:15–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sheppard KE, Cullinane C, Hannan KM, Wall
M, Chan J, Barber F, Foo J, Cameron D, Neilsen A, Ng P, et al:
Synergistic inhibition of ovarian cancer cell growth by combining
selective PI3K/mTOR and RAS/ERK pathway inhibitors. Eur J Cancer.
49:3936–3944. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kim KW, Moretti L, Mitchell LR, Jung DK
and Lu B: Combined Bcl-2/mammalian target of rapamycin inhibition
leads to enhanced radiosensitization via induction of apoptosis and
autophagy in non-small cell lung tumor xenograft model. Clin Cancer
Res. 15:6096–6105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Levine B, Sinha S and Kroemer G: Bcl-2
family members: Dual regulators of apoptosis and autophagy.
Autophagy. 4:600–606. 2008. View Article : Google Scholar :
|
|
50
|
Go EK, Jung KJ, Kim JY, Yu BP and Chung
HY: Betaine suppresses proinflammatory signaling during aging: The
involvement of nuclear factor-kappaB via nuclear factor-inducing
kinase/IkappaB kinase and mitogen-activated protein kinases. J
Gerontol A Biol Sci Med Sci. 60:1252–1264. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lin YG, Kunnumakkara AB, Nair A, Merritt
WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM,
Lutgendorf SK, et al: Curcumin inhibits tumor growth and
angiogenesis in ovarian carcinoma by targeting the nuclear
factor-kappaB pathway. Clin Cancer Res. 13:3423–3430. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jayasooriya RG, Choi YH, Moon SK, Kim WJ
and Kim GY: Methanol extract of Hydroclathrus clathratus suppresses
matrix metalloproteinase-9 in T24 bladder carcinoma cells by
suppressing the NF-κB and MAPK pathways. Oncol Rep. 27:541–546.
2012.PubMed/NCBI
|
|
53
|
Li W, Wang H, Kuang CY, Zhu JK, Yu Y, Qin
ZX, Liu J and Huang L: An essential role for the
Id1/PI3K/Akt/NF-κB/survivin signalling pathway in promoting the
proliferation of endothelial progenitor cells in vitro. Mol Cell
Biochem. 363:135–145. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sun CH, Chang YH and Pan CC: Activation of
the PI3K/Akt/mTOR pathway correlates with tumour progression and
reduced survival in patients with urothelial carcinoma of the
urinary bladder. Histopathology. 58:1054–1063. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Steelman LS, Abrams SL, Whelan J, Bertrand
FE, Ludwig DE, Bäsecke J, Libra M, Stivala F, Milella M, Tafuri A,
et al: Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and
Jak/STAT pathways to leukemia. Leukemia. 22:686–707. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang P, Pang X and Tu Y:
Thioredoxin-interacting protein as a common regulation target for
multiple drugs in clinical therapy/application. Cancer Transl Med.
1:26–30. 2015. View Article : Google Scholar
|
